Diabetes Metab J.  2023 May;47(3):345-346. 10.4093/dmj.2023.0125.

Navigating the Seas of Glycemic Control: The Role of Continuous Glucose Monitoring in Type 1 Diabetes Mellitus

• Moon JS

• KMID: 2542511
• DOI: http://doi.org/10.4093/dmj.2023.0125

Reference

1. Yoo JH, Kim JH. Advances in continuous glucose monitoring and integrated devices for management of diabetes with insulin-based therapy: improvement in glycemic control. Diabetes Metab J. 2023; 47:27–41.

2. Hur KY, Moon MK, Park JS, Kim SK, Lee SH, Yun JS, et al. 2021 Clinical practice guidelines for diabetes mellitus of the Korean Diabetes Association. Diabetes Metab J. 2021; 45:461–81.

3. ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 7. Diabetes technology: standards of care in diabetes-2023. Diabetes Care. 2023; 46(Suppl 1):S111–27.

4. Lee YB, Kim M, Kim JH. Glycemia according to the use of continuous glucose monitoring among adults with type 1 diabetes mellitus in Korea: a real-world study. Diabetes Metab J. 2023; 47:405–14.

5. Visser MM, Charleer S, Fieuws S, De Block C, Hilbrands R, Van Huffel L, et al. Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial. Lancet. 2021; 397:2275–83.

6. Visser MM, Charleer S, Fieuws S, De Block C, Hilbrands R, Van Huffel L, et al. Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes: 24-month results from the randomised ALERTT1 trial. Lancet Diabetes Endocrinol. 2023; 11:96–108.